FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jamie Waselenko

Research Profile

Disorders

Chemicals & Drugs

Physiology

Drug Resistance, Neoplasm

Procedures

Concepts & Ideas

Radiation Dosage

Activities & Behaviors

Clinical Trials, Phase I as Topic

Co-author Network

Publications

TOP 3
Daniel Weisdorf; Nelson Chao; Jamie K Waselenko; Nicholas Dainiak; James O Armitage; Ian K McNiece; Dennis L Confer
Acute radiation injury: contingency planning for triage, supportive care, and transplantation.
Carl R Willis; Amy Goodrich; Kathy Park; Jamie K Waselenko; Margaret Lucas; Amy Reese; Louis F Diehl; Michael R Grever; John C Byrd; Ian W Flinn
A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
Ronald E Goans; Jamie K Waselenko
Medical management of radiological casualties.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jamie Waselenko (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Daniel Weisdorf; Nelson Chao; Jamie K Waselenko; Nicholas Dainiak; James O Armitage; Ian K McNiece; Dennis L Confer
Acute radiation injury: contingency planning for triage, supportive care, and transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(6):672-82.
2006: Carl R Willis; Amy Goodrich; Kathy Park; Jamie K Waselenko; Margaret Lucas; Amy Reese; Louis F Diehl; Michael R Grever; John C Byrd; Ian W Flinn
A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
Annals of hematology 2006;85(5):301-7.
2005: Ronald E Goans; Jamie K Waselenko
Medical management of radiological casualties.
Health physics 2005;89(5):505-12.
2005: W L Jackson; C Gallagher; Rick C Myhand; Jamie K Waselenko
Medical management of patients with multiple organ dysfunction arising from acute radiation syndrome.
BJR supplement / BIR 2005;27():161-8.
2004: Jamie K Waselenko; Thomas J MacVittie; William F Blakely; Nicki Pesik; Albert L Wiley; William E Dickerson; Horace Tsu; Dennis L Confer; C Norman Coleman; Thomas Seed; Patrick Lowry; James O Armitage; Nicholas Dainiak
Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group.
Annals of internal medicine 2004;140(12):1037-51.
2004: Amy Belford; Otha Myles; Alan J Magill; James Wang; Rick C Myhand; Jamie K Waselenko
Thrombotic microangiopathy (TMA) and stroke due to human herpesvirus-6 (HHV-6) reactivation in an adult receiving high-dose melphalan with autologous peripheral stem cell transplantation.
American journal of hematology 2004;76(2):156-62.
2003: Jamie K Waselenko; Ann Burrows; Douglas A Nelson; Margaret Lucas; John Ekstrand; William Jeffrey Edenfield; Rick C Myhand
Post-transplant interleukin-2 in patients with low-grade lymphoid neoplasms previously treated with fludarabine is limited by hematologic toxicity.
Annals of hematology 2003;82(9):552-7.
2003: Nicholas Dainiak; Jamie K Waselenko; James O Armitage; Thomas J MacVittie; Ann Farese
The hematologist and radiation casualties.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2003;():473-96.
2001: Jamie K Waselenko; CA Shinn; Carl R Willis; Ian W Flinn; Michael R Grever; John C Byrd
Carboxyamido-triazole (CAI)--a novel "static" signal transduction inhibitor induces apoptosis in human B-cell chronic lymphocytic leukemia cells.
Leukemia & lymphoma 2001;42(5):1049-53.
2001: Jamie K Waselenko; Michael R Grever; CA Shinn; Ian W Flinn; John C Byrd
Gemcitabine demonstrates in vitro activity against human B-cell chronic lymphocytic leukemia.
Leukemia research 2001;25(6):435-40.
2001: John C Byrd; T Murphy; R S Howard; Margaret S Lucas; Amy Goodrich; Keunchil Park; M Pearson; Jamie K Waselenko; G Ling; Michael R Grever; A J Grillo-Lopez; J Rosenberg; L Kunkel; Ian W Flinn
Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2153-64.
2000: John C Byrd; Jamie K Waselenko; M Keating; Kanti Rai; Michael R Grever
Novel therapies for chronic lymphocytic leukemia in the 21st century.
Seminars in oncology 2000;27(5):587-97.
2000: Jamie K Waselenko; Michael R Grever; M Beer; M A Lucas; John C Byrd
Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
Seminars in oncology 2000;27(2 Suppl 5):44-51.
2000: John C Byrd; Michael R Grever; Jamie K Waselenko; Carl R Willis; Keunchil Park; Amy Goodrich; M A Lucas; CA Shinn; Ian W Flinn
Theophylline, pentostatin (Nipent), and chlorambucil: a dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders.
Seminars in oncology 2000;27(2 Suppl 5):37-40.
1999: John C Byrd; CA Shinn; Rajani Ravi; Carl R Willis; Jamie K Waselenko; Ian W Flinn; Nancy A Dawson; Michael R Grever
Depsipeptide (FR901228): a novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells.
Blood 1999;94(4):1401-8.
1999: John C Byrd; Jamie K Waselenko; T J Maneatis; T Murphy; F T Ward; B P Monahan; M A Sipe; S Donegan; Christine White
Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: association with increased infusion-related side effects and rapid blood tumor clearance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):791-5.
1998: R Michael Tuttle; Jamie K Waselenko; P Yosseffi; N Weigand; R K Martin
Preservation of nucleic acids for polymerase chain reaction after prolonged storage at room temperature.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1998;7(6):302-9.
1998: John C Byrd; CA Shinn; Jamie K Waselenko; Ephraim J Fuchs; T A Lehman; P L Nguyen; Ian W Flinn; Louis F Diehl; Edward A Sausville; Michael R Grever
Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53.
Blood 1998;92(10):3804-16.
1998: Jamie K Waselenko; M C Nace; Barbara M Alving
Women with thrombophilia: assessing the risks for thrombosis with oral contraceptives or hormone replacement therapy.
Seminars in thrombosis and hemostasis 1998;24 Suppl 1():33-9.
1997: Julie Kenner; Leonard C Sperling; Jamie K Waselenko; Nancy A Dawson; Purnima Sau; Judd W Moul
Suramin keratosis: a unique skin eruption in a patient receiving suramin for metastatic prostate cancer.
The Journal of urology 1997;158(6):2245-6.
1997: Jamie K Waselenko; Nancy A Dawson
Management of progressive metastatic prostate cancer.
Oncology (Williston Park, N.Y.) 1997;11(10):1551-60; discussion 1560-3, 1567-8.